NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial | MicrobiomeTrials← Back to trialsNCT06450041
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-12-16Est. Completion: 2028-12
Enrollment target: 62 participants Locations- Children's Hospital Los Angeles, Los Angeles, California, United States
- UCSF Benioff Children's Hospital, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Comer Children's Hospital, University of Chicago, Chicago, Illinois, United States
- Boston Children's Hospital, Dana-Farber Cancer Institute., Boston, Massachusetts, United States
- C.S Mott Children's Hospital, Ann Arbor, Michigan, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
- University of Texas Southwestern, Dallas, Texas, United States
- Cook Children's Medical Center, Fort Worth, Texas, United States
- Seattle Children's Hospital, Seattle, Washington, United States
Other microbiome trials you might be interested in
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch SyndromeRecurrent LymphomaRecurrent Malignant Solid NeoplasmRecurrent NeuroblastomaRecurrent Primary Central Nervous System NeoplasmRefractory LymphomaRefractory Malignant Solid NeoplasmRefractory NeuroblastomaRefractory Primary Central Nervous System NeoplasmXeroderma Pigmentosum
This phase Ib trial investigates the side effects of the combination of nivolumab and ipilimumab, and to see how well th…
Palo Alto, United StatesCompleted Jun 21, 2022
Somatostatin Receptor PositiveSmall Cell Lung CancersPheochromocytoma/ParagangliomasKidney CancersHead and Neck TumorsGastrointestinal Neuroendocrine TumorsOlfactory NeuroblastomaEsthesioneuroblastomaNasopharyngeal CarcinomaSinonasal Neuroendocrine Carcinoma
Background:
Some cancers have high levels of proteins called somatostatin receptors (SSTRs) on the surface of the tumor…
Bethesda, United StatesEst. completion Jan 1, 2029